Docket for 24-889
|
Dec 27 2024 | Application (24A652) to extend the time to file a petition for a writ of certiorari from January 15, 2025 to February 14, 2025, submitted to The Chief Justice. | | Main DocumentProof of Service | Jan 03 2025 | Application (24A652) granted by The Chief Justice extending the time to file until February 14, 2025. | | | Feb 14 2025 | Petition for a writ of certiorari filed. (Response due March 21, 2025) | | PetitionAppendixProof of ServiceCertificate of Word Count | Mar 04 2025 | Motion to extend the time to file a response from March 21, 2025 to April 21, 2025, submitted to The Clerk. | | Main Document | Mar 05 2025 | Motion to extend the time to file a response is granted and the time is extended to and including April 21, 2025. | | | Mar 20 2025 | Brief amici curiae of 30 Scholars of Law, Economics, and Medicine filed. | | Main DocumentProof of ServiceCertificate of Word Count | Mar 21 2025 | Brief amicus curiae of Association for Accessible Medicines filed. | | Main DocumentCertificate of Word CountProof of Service | Apr 04 2025 | Motion to extend the time to file a response from April 21, 2025 to May 15, 2025, submitted to The Clerk. | | Main Document | Apr 07 2025 | Motion to extend the time to file a response is granted and the time is further extended to and including May 15, 2025. | | | May 15 2025 | Brief of respondents Amarin Pharma, Inc., et al. in opposition filed. | | Main DocumentCertificate of Word CountProof of Service | Jun 02 2025 | Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. (Distributed) | | Main DocumentProof of ServiceCertificate of Word Count | Jun 03 2025 | DISTRIBUTED for Conference of 6/18/2025. | | | Jun 23 2025 | The Solicitor General is invited to file a brief in this case expressing the views of the United States. | | |
|